Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Controlling of glutamate release by neuregulin3 via inhibiting the assembly of the SNARE complex.

Wang YN, Figueiredo D, Sun XD, Dong ZQ, Chen WB, Cui WP, Liu F, Wang HS, Li HW, Robinson H, Fei EK, Pan BX, Li BM, Xiong WC, Mei L.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2508-2513. doi: 10.1073/pnas.1716322115. Epub 2018 Feb 20.

PMID:
29463705
2.

Neuregulin signaling pathway in smoking behavior.

Gupta R, Qaiser B, He L, Hiekkalinna TS, Zheutlin AB, Therman S, Ollikainen M, Ripatti S, Perola M, Salomaa V, Milani L, Cannon TD, Madden PAF, Korhonen T, Kaprio J, Loukola A.

Transl Psychiatry. 2017 Aug 22;7(8):e1212. doi: 10.1038/tp.2017.183.

3.

Neuregulin 3 and its roles in schizophrenia risk and presentation.

Avramopoulos D.

Am J Med Genet B Neuropsychiatr Genet. 2018 Mar;177(2):257-266. doi: 10.1002/ajmg.b.32552. Epub 2017 May 29. Review.

PMID:
28556469
4.

Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.

Paterson C, Wang Y, Hyde TM, Weinberger DR, Kleinman JE, Law AJ.

Am J Psychiatry. 2017 Mar 1;174(3):256-265. doi: 10.1176/appi.ajp.2016.16060721. Epub 2016 Oct 24.

5.

Neuregulin 3 Knockout Mice Exhibit Behaviors Consistent with Psychotic Disorders.

Hayes LN, Shevelkin A, Zeledon M, Steel G, Chen PL, Obie C, Pulver A, Avramopoulos D, Valle D, Sawa A, Pletnikov MV.

Mol Neuropsychiatry. 2016 Jul;2(2):79-87. doi: 10.1159/000445836. Epub 2016 May 20.

6.

Secondary association of PDLIM5 with paranoid schizophrenia in Emirati patients.

Moselhy H, Eapen V, Akawi NA, Younis A, Salih B, Othman AR, Yousef S, Clarke RA, Ali BR.

Meta Gene. 2015 Jul 21;5:135-9. doi: 10.1016/j.mgene.2015.07.002. eCollection 2015 Sep.

7.

Identification and functional studies of regulatory variants responsible for the association of NRG3 with a delusion phenotype in schizophrenia.

Zeledón M, Eckart N, Taub M, Vernon H, Szymanksi M, Wang R, Chen PL, Nestadt G, McGrath JA, Sawa A, Pulver AE, Avramopoulos D, Valle D.

Mol Neuropsychiatry. 2015 May;1(1):36-46. Epub 2015 Feb 27.

8.

Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders.

Fisher ML, Loukola A, Kaprio J, Turner JR.

Int Rev Neurobiol. 2015;124:113-31. doi: 10.1016/bs.irn.2015.07.006. Epub 2015 Sep 16. Review.

9.

Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.

Hu X, Fan Q, Hou H, Yan R.

J Neurochem. 2016 Jan;136(2):234-49. doi: 10.1111/jnc.13395. Epub 2015 Nov 13. Review.

10.

PTPN21 exerts pro-neuronal survival and neuritic elongation via ErbB4/NRG3 signaling.

Plani-Lam JH, Chow TC, Siu KL, Chau WH, Ng MH, Bao S, Ng CT, Sham P, Shum DK, Ingley E, Jin DY, Song YQ.

Int J Biochem Cell Biol. 2015 Apr;61:53-62. doi: 10.1016/j.biocel.2015.02.003. Epub 2015 Feb 11.

PMID:
25681686
11.

Impulsivity and comorbid traits: a multi-step approach for finding putative responsible microRNAs in the amygdala.

Pietrzykowski AZ, Spijker S.

Front Neurosci. 2014 Dec 11;8:389. doi: 10.3389/fnins.2014.00389. eCollection 2014.

12.

Transient overexposure of neuregulin 3 during early postnatal development impacts selective behaviors in adulthood.

Paterson C, Law AJ.

PLoS One. 2014 Aug 5;9(8):e104172. doi: 10.1371/journal.pone.0104172. eCollection 2014.

13.

Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia.

Díez A, Cieza-Borrella C, Suazo V, González-Sarmiento R, Papiol S, Molina V.

Ann Gen Psychiatry. 2014 Jun 14;13:18. doi: 10.1186/1744-859X-13-18. eCollection 2014.

14.

Neuregulin-3 in the mouse medial prefrontal cortex regulates impulsive action.

Loos M, Mueller T, Gouwenberg Y, Wijnands R, van der Loo RJ; Neuro-BSIK Mouse Phenomics Consortium, Birchmeier C, Smit AB, Spijker S.

Biol Psychiatry. 2014 Oct 15;76(8):648-55. doi: 10.1016/j.biopsych.2014.02.011. Epub 2014 Feb 24.

PMID:
24703509
15.

Effects of neuregulin 3 genotype on human prefrontal cortex physiology.

Tost H, Callicott JH, Rasetti R, Vakkalanka R, Mattay VS, Weinberger DR, Law AJ.

J Neurosci. 2014 Jan 15;34(3):1051-6. doi: 10.1523/JNEUROSCI.3496-13.2014.

16.

Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample.

Loukola A, Wedenoja J, Keskitalo-Vuokko K, Broms U, Korhonen T, Ripatti S, Sarin AP, Pitkäniemi J, He L, Häppölä A, Heikkilä K, Chou YL, Pergadia ML, Heath AC, Montgomery GW, Martin NG, Madden PA, Kaprio J.

Mol Psychiatry. 2014 May;19(5):615-24. doi: 10.1038/mp.2013.72. Epub 2013 Jun 11.

17.

Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients.

Hatzimanolis A, McGrath JA, Wang R, Li T, Wong PC, Nestadt G, Wolyniec PS, Valle D, Pulver AE, Avramopoulos D.

Transl Psychiatry. 2013 May 28;3:e264. doi: 10.1038/tp.2013.33.

18.

A proximity-based method to identify genomic regions correlated with a continuously varying environmental variable.

Di Gaetano C, Matullo G, Piazza A, Ursino M, Gasparini M.

Evol Bioinform Online. 2013;9:29-42. doi: 10.4137/EBO.S10211. Epub 2013 Jan 29.

19.

No genetic evidence for Neuregulin 3 conferring risk of schizophrenia in the Chinese population.

Zhang R, Du XY, Yu J, Xu N, Zheng YW, Zhao YL, Zhang H, Ma J.

Psychiatry Res. 2013 Feb 28;205(3):279-81. doi: 10.1016/j.psychres.2012.08.017. Epub 2012 Sep 13.

PMID:
22981155
20.

Allele-biased expression in differentiating human neurons: implications for neuropsychiatric disorders.

Lin M, Hrabovsky A, Pedrosa E, Wang T, Zheng D, Lachman HM.

PLoS One. 2012;7(8):e44017. doi: 10.1371/journal.pone.0044017. Epub 2012 Aug 30.

Supplemental Content

Loading ...
Support Center